<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="3" ids="16335">Adenosine</z:chebi> A(2A) receptor <z:chebi fb="68" ids="48706">antagonists</z:chebi> have been proved protective in different <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> models </plain></SENT>
<SENT sid="1" pm="."><plain>In this study we verified if the protective effect of the selective A(2A) <z:chebi fb="68" ids="48706">antagonist</z:chebi>, SCH 58261, could be attributed to the reduction of the excitatory amino acid outflow induced by cerebral focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>A vertical microdialysis probe was inserted into the striatum of male Wistar rats and, after 24 h, permanent right intraluminal middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAo) was induced </plain></SENT>
<SENT sid="3" pm="."><plain>Soon after waking, rats showed a definite contralateral turning behavior, which persisted up to 7 h after MCAo </plain></SENT>
<SENT sid="4" pm="."><plain>During 4 h after MCAo, <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi>, <z:chebi fb="0" ids="29995">aspartate</z:chebi>, <z:chebi fb="3" ids="16865">GABA</z:chebi>, <z:chebi fb="3" ids="16335">adenosine</z:chebi> and <z:chebi fb="5" ids="15891">taurine</z:chebi> outflow increased </plain></SENT>
<SENT sid="5" pm="."><plain>SCH 58261 (0.01 mg/kg, i.p.), administered 5 min after MCAo, suppressed turning behavior and significantly reduced the outflow of <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi>, <z:chebi fb="0" ids="29995">aspartate</z:chebi>, <z:chebi fb="3" ids="16865">GABA</z:chebi> and <z:chebi fb="3" ids="16335">adenosine</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>At 24 h after MCAo, the rats showed severe sensorimotor deficit and damage in both the striatum and cortex </plain></SENT>
<SENT sid="7" pm="."><plain>SCH 58261 significantly reduced cortical damage but did not protect against the sensorimotor deficit </plain></SENT>
<SENT sid="8" pm="."><plain>The protective effect of SCH 58261 against turning behavior and increased outflow of excitatory amino acids in the first hours after MCAo suggests the potential utility of selective <z:chebi fb="3" ids="16335">adenosine</z:chebi> A(2A) <z:chebi fb="68" ids="48706">antagonists</z:chebi> when administered in the first hours after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Furthermore, this study, for the first time, proposes that turning behavior after permanent intraluminal MCAo, be used as a precocious index of neurological deficit and neuronal damage </plain></SENT>
</text></document>